Mechanism of photosensitive reactions induced by piroxicam. 1989

J L Cirne de Castro, and E Vale, and M Martins

UI MeSH Term Description Entries
D010787 Photosensitivity Disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy. Actinic Reticuloid Syndrome,Dermatitis, Actinic,Photodermatitis,Chronic Actinic Dermatitis,Photosensitization,Actinic Dermatitides,Actinic Dermatitides, Chronic,Actinic Dermatitis,Actinic Dermatitis, Chronic,Actinic Reticuloid Syndromes,Chronic Actinic Dermatitides,Dermatitides, Actinic,Dermatitides, Chronic Actinic,Dermatitis, Chronic Actinic,Disorder, Photosensitivity,Disorders, Photosensitivity,Photodermatitides,Photosensitivity Disorder,Reticuloid Syndrome, Actinic,Reticuloid Syndromes, Actinic,Syndrome, Actinic Reticuloid,Syndromes, Actinic Reticuloid
D010894 Piroxicam A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. CP-16171,Feldene,CP 16171,CP16171
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005035 Ethylmercury Compounds Organic mercury compounds in which the mercury is attached to an ethyl group. Ethyl Mercury Compounds,Ethylmercurials,Compounds, Ethyl Mercury,Compounds, Ethylmercury,Mercury Compounds, Ethyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013849 Thimerosal An ethylmercury-sulfidobenzoate that has been used as a preservative in VACCINES; ANTIVENINS; and OINTMENTS. It was formerly used as a topical antiseptic. It degrades to ethylmercury and thiosalicylate. Mercurothiolate,Thiomersal,Thiomersalate,Merthiolate,Sodium Ethylmercurithiosalicylate,Vitaseptol,Ethylmercurithiosalicylate, Sodium

Related Publications

J L Cirne de Castro, and E Vale, and M Martins
December 1986, Journal of the American Academy of Dermatology,
J L Cirne de Castro, and E Vale, and M Martins
November 1986, Archives of dermatology,
J L Cirne de Castro, and E Vale, and M Martins
October 1998, Archives of internal medicine,
J L Cirne de Castro, and E Vale, and M Martins
September 1987, Drug intelligence & clinical pharmacy,
J L Cirne de Castro, and E Vale, and M Martins
January 1983, Acta dermato-venereologica,
J L Cirne de Castro, and E Vale, and M Martins
November 1998, Acta medica portuguesa,
J L Cirne de Castro, and E Vale, and M Martins
August 1989, Photo-dermatology,
J L Cirne de Castro, and E Vale, and M Martins
March 1995, Presse medicale (Paris, France : 1983),
J L Cirne de Castro, and E Vale, and M Martins
January 1982, Medicina cutanea ibero-latino-americana,
Copied contents to your clipboard!